189(top 100%)
papers
14.3K(top 1%)
citations
49(top 100%)
h-index
115(top 100%)
g-index
237
all documents
18.1K
doc citations
4.1K
citing journals
100
times ranked

Publications

212 papers • 18,093 citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Rapid reviews methods series: Guidance on assessing the certainty of evidence
BMJ Evidence-Based Medicine, 2024, 29, 50-54
1.125Citations (PDF)
2Psychotherapies for the treatment of borderline personality disorder: A systematic review.
Journal of Consulting and Clinical Psychology, 2024, 92, 275-295
1.027Citations (PDF)
3Rapid review methods series: Guidance on the use of supportive software
BMJ Evidence-Based Medicine, 2024, 29, 264-271
1.112Citations (PDF)
4Data extraction for evidence synthesis using a large language model: A proof‐of‐concept study
Research Synthesis Methods, 2024, 15, 576-589
1.0102Citations (PDF)
5Pharmacological interventions for the management of children and adolescents living with obesity—An update of a Cochrane systematic review with meta‐analyses
Pediatric Obesity, 2024, 19,
0.522Citations (PDF)
6Update Alert: Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians
Annals of Internal Medicine, 2024, 177,
2.16Citations (PDF)
7Performance of two large language models for data extraction in evidence synthesis
Research Synthesis Methods, 2024, 15, 818-824
1.047Citations (PDF)
8Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2, Update Alert)
Annals of Internal Medicine, 2024, 177,
2.12Citations (PDF)
9Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians
Annals of Internal Medicine, 2023, 176, 92-104
2.112Citations (PDF)
10Values and Preferences of Patients With Depressive Disorders Regarding Pharmacologic and Nonpharmacologic Treatments
Annals of Internal Medicine, 2023, 176, 217-223
2.110Citations (PDF)
11Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians
Annals of Internal Medicine, 2023, 176, 196-211
2.135Citations (PDF)
12Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder
Annals of Internal Medicine, 2023, 176, 212-216
2.12Citations (PDF)
13WHO-Leitlinie: Leitfaden für die medikamentöse Behandlung von Bluthochdruck bei Erwachsenen
Gesundheitswesen, 2023, 85, 139-142
0.23Citations (PDF)
14Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment
BMJ Evidence-Based Medicine, 2023, 28, 418-423
1.159Citations (PDF)
15Rapid reviews methods series: Guidance on literature search
BMJ Evidence-Based Medicine, 2023, 28, 412-417
1.162Citations (PDF)
16Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Evidence Review for the American College of Physicians (Version 2)
Annals of Internal Medicine, 2023, 176, 1377-1385
2.111Citations (PDF)
17Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure - A systematic review
Science of the Total Environment, 2022, 806, 150480
1.524Citations (PDF)
18Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment
Annals of Internal Medicine, 2022, 175, 256-266
2.129Citations (PDF)
19Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis
BMJ Evidence-Based Medicine, 2022, 27, 345-351
1.117Citations (PDF)
20Crowdsourcing the identification of studies for <scp>COVID</scp>‐19‐related Cochrane Rapid Reviews
Research Synthesis Methods, 2022, 13, 585-594
1.04Citations (PDF)
21Searching two or more databases decreased the risk of missing relevant studies: a metaresearch study
Journal of Clinical Epidemiology, 2022, 149, 154-164
0.7109Citations (PDF)
22A REVIEW ON THE RELATIONSHIP BETWEEN NIDRA QUALITY AND MENTAL HEALTH: A PHYSIOLOGICAL ASPECT
International Journal of Research in Ayurveda and Pharmacy, 2022, 13, 104-110
0.00Citations (PDF)
23Developing trustworthy recommendations as part of an urgent response (1–2 weeks): a GRADE concept paper
Journal of Clinical Epidemiology, 2021, 129, 1-11
0.733Citations (PDF)
24Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews
Journal of Clinical Epidemiology, 2021, 130, 13-22
0.7889Citations (PDF)
25Citation screening using crowdsourcing and machine learning produced accurate results: Evaluation of Cochrane's modified Screen4Me service
Journal of Clinical Epidemiology, 2021, 130, 23-31
0.750Citations (PDF)
26Filamentous Fungal Infections in a Tertiary Care Setting: Epidemiology and Clinical Outcome
Journal of Fungi (Basel, Switzerland), 2021, 7, 40
0.74Citations (PDF)
27Paracoccidioidomycosis Diagnosed in Europe—A Systematic Literature Review
Journal of Fungi (Basel, Switzerland), 2021, 7, 157
0.723Citations (PDF)
28Second-generation antidepressants for treatment of seasonal affective disorder
The Cochrane Library, 2021, 2021,
0.56Citations (PDF)
29Point-of-Care Ultrasonography in Patients With Acute Dyspnea: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians
Annals of Internal Medicine, 2021, 174, 967-976
2.148Citations (PDF)
30The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review
Journal of Clinical Epidemiology, 2021, 135, 125-135
0.727Citations (PDF)
31Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis
CNS Drugs, 2021, 35, 1053-1067
1.391Citations (PDF)
32What are the Relevant Outcomes of the Periodic Health Examination? A Comparison of Citizens’ and Experts’ Ratings
Patient Preference and Adherence, 2021, Volume 15, 57-68
0.33Citations (PDF)
33Authors’ Reply to Pereira Ribeiro et al.: Comment on “Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta‑Analysis”
CNS Drugs, 2021, 35, 1335-1336
1.32Citations (PDF)
34Defining treatment‐resistant depression
Depression and Anxiety, 2020, 37, 134-145
0.2367Citations (PDF)
35WHO-Leitlinie: Beratung von Müttern zur Verbesserung von Stillpraktiken
Gesundheitswesen, 2020, 82, 274-279
0.26Citations (PDF)
36GRADE-Leitlinien zu Gerechtigkeit 4. Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: von der Evidenz zur Empfehlung
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2020, 156-157, 105-112
0.20Citations (PDF)
37GRADE-Leitlinien zu Gerechtigkeit 3: Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: Vertrauenswürdigkeit der Evidenz beurteilen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2020, 153-154, 119-125
0.20Citations (PDF)
38Household interventions for secondary prevention of domestic lead exposure in children
The Cochrane Library, 2020, 2020,
0.511Citations (PDF)
39Efficacy and safety of immune checkpoint inhibitors in patients with advanced non–small cell lung cancer (NSCLC): a systematic literature review
OncoImmunology, 2020, 9,
0.947Citations (PDF)
40Identifying outcomes for depression that matter to patients, informal caregivers, and health-care professionals: qualitative content analysis of a large international online survey
Lancet Psychiatry,the, 2020, 7, 692-702
1.1163Citations (PDF)
41Combining abbreviated literature searches with single-reviewer screening: three case studies of rapid reviews
Systematic Reviews, 2020, 9,
0.821Citations (PDF)
42The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis
Scientific Reports, 2020, 10,
0.8141Citations (PDF)
43Abbreviated and comprehensive literature searches led to identical or very similar effect estimates: a meta-epidemiological study
Journal of Clinical Epidemiology, 2020, 128, 1-12
0.719Citations (PDF)
44Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes
The Cochrane Library, 2020, 2020,
0.527Citations (PDF)
45Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review
The Cochrane Library, 2020, 2020,
0.5197Citations (PDF)
46Universal screening for SARS-CoV-2 infection: a rapid review
The Cochrane Library, 2020, 2020,
0.554Citations (PDF)
47Screening for Hypertension in Children and Adolescents
JAMA - Journal of the American Medical Association, 2020, 324, 1884
1.656Citations (PDF)
48Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial
Journal of Clinical Epidemiology, 2020, 121, 20-28
0.7154Citations (PDF)
49GRADE-Leitlinien: 18. Wie ROBINS-I und andere Instrumente zur Einschätzung des Risikos für Bias von nicht-randomisierten Studien verwendet werden sollten, um die Vertrauenswürdigkeit eines Evidenzkörpers zu bewerten
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2020, 150-152, 124-133
0.211Citations (PDF)
50Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes
The Cochrane Library, 2020, 2020,
0.557Citations (PDF)
51Reply to letter to the editor “Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry”
Journal of Clinical Epidemiology, 2020, 123, 173-174
0.74Citations (PDF)
52Quarantäne alleine oder in Kombination mit weiteren Public-Health-Maßnahmen zur Eindämmung der COVID-19 Pandemie: Ein Cochrane Rapid Review
Gesundheitswesen, 2020, 82, 501-506
0.226Citations (PDF)
53The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
F1000Research, 2020, 9, 1193
0.145Citations (PDF)
54The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
F1000Research, 2020, 9, 1193
0.145Citations (PDF)
55WHO-Leitlinie: Prävention und Kontrolle von Tuberkulose-Infektionen
Gesundheitswesen, 2020, 82, 885-889
0.220Citations (PDF)
56Comparative Effectiveness of Combining MTX with Biologic Drug Therapy Versus Either MTX or Biologics Alone for Early Rheumatoid Arthritis in Adults: a Systematic Review and Network Meta-analysis
Journal of General Internal Medicine, 2019, 34, 2232-2245
0.631Citations (PDF)
57Evidenzbasierte Empfehlungen zur Überarbeitung der österreichischen Vorsorgeuntersuchung
Wiener Medizinische Wochenschrift, 2019, 169, 339-349
0.22Citations (PDF)
58Continuing education for the prevention of mild cognitive impairment and Alzheimer’s-type dementia: a systematic review and overview of systematic reviews
BMJ Open, 2019, 9, e027719
0.452Citations (PDF)
59GRADE Evidence-to-Decision-Tabellen für die Übernahme, Anpassung und De-novo-Entwicklung von vertrauenswürdigen Empfehlungen: GRADE-ADOLOPMENT
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2019, 144-145, 90-99
0.21Citations (PDF)
60Assessing the accuracy of machine-assisted abstract screening with DistillerAI: a user study
Systematic Reviews, 2019, 8,
0.843Citations (PDF)
61Second-generation antidepressants for preventing seasonal affective disorder in adults
The Cochrane Library, 2019, 2019,
0.510Citations (PDF)
62GRADE-Leitlinien zu Gerechtigkeit 1. Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: Einführung und Hintergründe
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2019, 146, 53-59
0.24Citations (PDF)
63Comparison of transcatheter aortic valve implantation with other approaches to treat aortic valve stenosis: a systematic review and meta-analysis
Systematic Reviews, 2019, 8,
0.818Citations (PDF)
64GRADE-Leitlinien zu Gerechtigkeit 2. Berücksichtigung der Gerechtigkeit im Gesundheitswesen bei der Entwicklung von GRADE-Leitlinien: Erweiterung der Checkliste zur Entwicklung von Leitlinien
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2019, 147-148, 120-126
0.22Citations (PDF)
65Melatonin and agomelatine for preventing seasonal affective disorder
The Cochrane Library, 2019, 2019,
0.510Citations (PDF)
66A case report of a 40-year-old woman with endomyocardial fibrosis in a non-tropical area: from initial presentation to high urgent heart transplantation
BMC Cardiovascular Disorders, 2019, 19,
0.47Citations (PDF)
67The comparative efficacy and risk of harms of the intravenous and subcutaneous formulations of trastuzumab in patients with HER2-positive breast cancer: a rapid review
Systematic Reviews, 2019, 8,
0.88Citations (PDF)
68Risikokommunikation in gesundheitsbedrohlichen Krisensituationen: Zusammenfassung einer WHO-Leitlinie
Gesundheitswesen, 2019, 81, 846-849
0.214Citations (PDF)
69Increased risks for random errors are common in outcomes graded as high certainty of evidence
Journal of Clinical Epidemiology, 2019, 106, 50-59
0.759Citations (PDF)
70GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
Journal of Clinical Epidemiology, 2019, 111, 105-114
0.7670Citations (PDF)
71Light therapy for preventing seasonal affective disorder
The Cochrane Library, 2019, 2019,
0.527Citations (PDF)
72GRADE-Leitlinien: 17. Beurteilung des Bias-Risikos durch fehlende Endpunkt-Daten im Evidenzkörper
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2019, 149, 73-81
0.22Citations (PDF)
73GRADE-Leitlinien: 16. Von der Evidenz zur Empfehlung oder Entscheidung – Vorgehen nach GRADE für Tests in der klinischen Praxis und in Public Health
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2018, 133, 58-66
0.212Citations (PDF)
74Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis
Journal of Affective Disorders, 2018, 228, 1-12
0.954Citations (PDF)
75German language questionnaires for assessing implementation constructs and outcomes of psychosocial and health-related interventions: a systematic review
Implementation Science, 2018, 13,
1.218Citations (PDF)
76Implementing prevention of seasonal affective disorder from patients’ and physicians’ perspectives – a qualitative study
BMC Psychiatry, 2018, 18,
0.616Citations (PDF)
77Participants’ expectations and experiences with periodic health examinations in Austria - a qualitative study
BMC Health Services Research, 2018, 18,
0.414Citations (PDF)
78Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta-analysis
Scientific Reports, 2018, 8,
0.8357Citations (PDF)
79GRADE: Von der Evidenz zur Empfehlung oder Entscheidung - ein systematischer und transparenter Ansatz, um gut informierte Entscheidungen im Gesundheitswesen zu treffen. 1: Einleitung
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2018, 134, 57-66
0.216Citations (PDF)
80Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review
The Cochrane Library, 2018, 2018,
0.512Citations (PDF)
81Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis
Primary Care Diabetes, 2018, 12, 393-408
0.4185Citations (PDF)
82Abbreviated literature searches were viable alternatives to comprehensive searches: a meta-epidemiological study
Journal of Clinical Epidemiology, 2018, 102, 1-11
0.756Citations (PDF)
83Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
The Cochrane Library, 2018, 2018,
0.514Citations (PDF)
84Prevalence of mental disorders in young refugees and asylum seekers in European Countries: a systematic review
European Child and Adolescent Psychiatry, 2018, 28, 1295-1310
0.5268Citations (PDF)
85The GRADE Working Group clarifies the construct of certainty of evidence
Journal of Clinical Epidemiology, 2017, 87, 4-13
0.7637Citations (PDF)
86Vitamin D deficiency as a risk factor for dementia: a systematic review and meta-analysis
BMC Geriatrics, 2017, 17,
0.5112Citations (PDF)
87Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
BMJ Open, 2017, 7, e014912
0.4157Citations (PDF)
88Community gardening, community farming and other local community-based gardening interventions to prevent overweight and obesity in high-income and middle-income countries: protocol for a systematic review
BMJ Open, 2017, 7, e016237
0.49Citations (PDF)
89Comparative Benefits and Harms of Complementary and Alternative Medicine Therapies for Initial Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis
Journal of Alternative and Complementary Medicine, 2017, 23, 907-919
2.528Citations (PDF)
90Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
JAMA - Journal of the American Medical Association, 2017, 318, 2234
1.6137Citations (PDF)
91Trading certainty for speed - how much uncertainty are decisionmakers and guideline developers willing to accept when using rapid reviews: an international survey
BMC Medical Research Methodology, 2017, 17,
0.543Citations (PDF)
92User testing of an adaptation of fishbone diagrams to depict results of systematic reviews
BMC Medical Research Methodology, 2017, 17,
0.514Citations (PDF)
93Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 2016, 164, 331
2.1110Citations (PDF)
94Effectiveness evaluation of a health promotion programme in primary schools: a cluster randomised controlled trial
BMC Public Health, 2016, 16,
0.518Citations (PDF)
95How contextual issues can distort shared decision making
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2016, 118-119, 17-23
0.25Citations (PDF)
96Health effects of cow’s milk consumption in infants up to 3 years of age: a systematic review and meta-analysis
Public Health Nutrition, 2016, 19, 293-307
0.541Citations (PDF)
97Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression
Annals of Internal Medicine, 2016, 165, 454
2.16Citations (PDF)
98The skills and experience of GRADE methodologists can be assessed with a simple tool
Journal of Clinical Epidemiology, 2016, 79, 150-158.e1
0.7134Citations (PDF)
99Authors’ reply to Gøtzsche and Hamilton
BMJ, The, 2016, , i617
0.20Citations (PDF)
100Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review
BMC Pregnancy and Childbirth, 2016, 16,
0.447Citations (PDF)
101Cochrane Rapid Reviews Methods Group to play a leading role in guiding the production of informed high-quality, timely research evidence syntheses
Systematic Reviews, 2016, 5,
0.849Citations (PDF)
102Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review
Arthritis Care and Research, 2016, 68, 1078-1088
0.826Citations (PDF)
103Average effect estimates remain similar as evidence evolves from single trials to high-quality bodies of evidence: a meta-epidemiologic study
Journal of Clinical Epidemiology, 2016, 69, 16-22
0.76Citations (PDF)
104The predictive validity of quality of evidence grades for the stability of effect estimates was low: a meta-epidemiological study
Journal of Clinical Epidemiology, 2016, 70, 52-60
0.720Citations (PDF)
105Vergleichende Evaluierung von Informationsprodukten zu Krebsscreening der deutschsprachigen Krebs-Organisationen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2015, 109, 350-362
0.24Citations (PDF)
106How effective are common medications: a perspective based on meta-analyses of major drugs
BMC Medicine, 2015, 13,
1.291Citations (PDF)
107Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews
BMC Public Health, 2015, 15,
0.5312Citations (PDF)
108Inadequate use and regulation of interventions against publication bias decreases their effectiveness: a systematic review
Journal of Clinical Epidemiology, 2015, 68, 792-802
0.739Citations (PDF)
109Leitlinienentwicklung: von der Evidenz zu Empfehlungen Möglichkeiten und Herausforderungen aus Sicht der MethodikerInnen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2015, 109, 319-329
0.26Citations (PDF)
110Wie evidenzbasiert berichten Print- und Online-Medien in Österreich? Eine quantitative Analyse
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2015, 109, 341-349
0.210Citations (PDF)
111Vergleichende Wirksamkeit und Sicherheit von Screeninguntersuchungen und Beratungsgesprächen durch nicht-ärztliches und ärztliches Personal. Eine systematische Übersichtsarbeit
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2015, 109, 18-27
0.20Citations (PDF)
112Grades for quality of evidence were associated with distinct likelihoods that treatment effects will remain stable
Journal of Clinical Epidemiology, 2015, 68, 489-497
0.74Citations (PDF)
113Grading the strength of a body of evidence when assessing health care interventions: an EPC update
Journal of Clinical Epidemiology, 2015, 68, 1312-1324
0.7245Citations (PDF)
114Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
Journal of Clinical Psychiatry, 2015, 75, 477-489
0.5302Citations (PDF)
115Perioperatives Anämiemanagement – Systematischer Review und Meta-Analyse
Wiener Medizinische Wochenschrift, 2014, 164, 330-341
0.23Citations (PDF)
116Barriers to and facilitators of interventions to counter publication bias: thematic analysis of scholarly articles and stakeholder interviews
BMC Health Services Research, 2014, 14,
0.419Citations (PDF)
117SAMURAI: Sensitivity analysis of a meta-analysis with unpublished but registered analytical investigations (software)
Systematic Reviews, 2014, 3,
0.84Citations (PDF)
118Grade Leitlinien: 15. Von der Evidenz zur Empfehlung – Determinanten, die Richtung und Stärke einer Empfehlung bestimmen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2014, 108, 421-431
0.26Citations (PDF)
119GRADE Leitlinien: 14. Von der Evidenz zur Empfehlung: Die Bedeutung und Darstellung von Empfehlungen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2014, 108, 413-420
0.235Citations (PDF)
120GRADE Leitlinien: 13. Erstellen von Summary-of-Findings-Tabellen und Evidenzprofilen – kontinuierliche Endpunkte
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2014, 108, 333-347
0.28Citations (PDF)
121Comparative Efficacy and Risk of Harms of Immediate- versus Extended-Release Second-Generation Antidepressants: A Systematic Review with Network Meta-Analysis
CNS Drugs, 2014, 28, 699-712
1.318Citations (PDF)
122Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
Diabetologia, 2014, 58, 242-254
1.348Citations (PDF)
123Comparative Risk for Harms of Second-Generation Antidepressants
Drug Safety, 2013, 31, 851-865
0.8111Citations (PDF)
124The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder
Drug Safety, 2013, 32, 1159-1173
0.830Citations (PDF)
125GRADE-Leitlinien: 12. Erstellen von „Summary-of-Findings“-Tabellen – Dichotome Endpunkte
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2013, 107, 646-664
0.219Citations (PDF)
126The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses
Journal of Clinical Epidemiology, 2013, 66, 736-742.e5
0.7337Citations (PDF)
127GRADE-Leitlinien: 11. Gesamtbeurteilung des Vertrauens in Effektschätzer für einen einzelnen Studienendpunkt und für alle Endpunkte
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2013, 107, 638-645
0.213Citations (PDF)
128GRADE-Leitlinien: 10. Den Ressourcenverbrauch berücksichtigen und die Qualität ökonomischer Evidenz bewerten
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2013, 107, 256-268
0.23Citations (PDF)
129GRADE-Leitlinien: 9. Heraufstufen der Qualität der Evidenz
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2013, 107, 249-255
0.213Citations (PDF)
130A case study of pooled-studies publications indicated potential for both valuable information and bias
Journal of Clinical Epidemiology, 2013, 66, 1082-1092
0.76Citations (PDF)
131Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: A systematic review and meta-analysis
European Journal of Cancer, 2013, 49, 812-825
0.555Citations (PDF)
132Interventions to Prevent Post-Traumatic Stress Disorder
American Journal of Preventive Medicine, 2013, 44, 635-650
0.8134Citations (PDF)
133Adjunct ultrasonography for breast cancer screening in women at average risk: a systematic review
International Journal of Evidence-Based Healthcare, 2013, 11, 87-93
0.522Citations (PDF)
134Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
Drug Safety, 2013, 37, 19-31
0.8145Citations (PDF)
135Functional Outcomes of Drug Treatment in Alzheimer???s Disease
Drugs and Aging, 2012, 24, 155-167
0.556Citations (PDF)
136The Impact of Inclusion Criteria in Health Economic Assessments
Applied Health Economics and Health Policy, 2012, 9, 139-148
0.54Citations (PDF)
137Klinische Ergebnisse, gesundheitsbezogene Lebensqualität und Kosten-Effektivität eines 6-monatigen Programms zur Lebensstilmodifikation bei Personen mit erhöhtem kardioväskularen Risiko in Niederösterreich
Wiener Medizinische Wochenschrift, 2012, 162, 321-329
0.21Citations (PDF)
138GRADE-Leitlinien: 3. Bewertung der Qualität der Evidenz (Vertrauen in die Effektschätzer)
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 449-456
0.266Citations (PDF)
139GRADE-Leitlinien: 4. Bewertung der Qualität der Evidenz – Studienlimitationen (Risiko für Bias)
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 457-469
0.220Citations (PDF)
140GRADE Leitlinien: 5. Einschätzung der Qualität der Evidenz – Publikationsbias
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 670-676
0.222Citations (PDF)
141GRADE Leitlinien: 6. Einschätzung der Qualität der Evidenz – Unzureichende Präzision
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 677-688
0.233Citations (PDF)
142GRADE Leitlinien: 7. Einschätzung der Qualität der Evidenz – Inkonsistenz
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 733-744
0.221Citations (PDF)
143GRADE Leitlinien: 8. Einschätzung der Qualität der Evidenz – Indirektheit
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 745-753
0.218Citations (PDF)
144GRADE-Leitlinien: 1. Einführung – GRADE-Evidenzprofile und Summary-of-Findings-Tabellen
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 357-368
0.295Citations (PDF)
145GRADE-Leitlinien: 2. Formulierung der Fragestellung und Entscheidung über wichtige Endpunkte
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2012, 106, 369-376
0.214Citations (PDF)
146Quantifying the unquantifiable
Journal of Clinical Epidemiology, 2012, 65, 234-235
0.70Citations (PDF)
147Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis
Annals of Pharmacotherapy, 2012, 46, 1491-1505
0.516Citations (PDF)
148Evidenzbasierte Medizin in der Praxis
Sports Orthopaedics and Traumatology, 2012, 28, 233-243
0.01Citations (PDF)
149How Should Primary Care Doctors Select Which Antidepressants to Administer?
Current Psychiatry Reports, 2012, 14, 360-369
1.526Citations (PDF)
150Methods for the Drug Effectiveness Review Project
BMC Medical Research Methodology, 2012, 12,
0.528Citations (PDF)
151Cochrane Review: Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents
Evidence-Based Child Health: A Cochrane Review Journal, 2012, 7, 1015-1038
3.10Citations (PDF)
152COMPARATIVE EFFECTIVENESS OF SECOND-GENERATION ANTIDEPRESSANTS FOR ACCOMPANYING ANXIETY, INSOMNIA, AND PAIN IN DEPRESSED PATIENTS: A SYSTEMATIC REVIEW
Depression and Anxiety, 2012, 29, 495-505
0.255Citations (PDF)
153CLINICAL HETEROGENEITY IN SYSTEMATIC REVIEWS AND HEALTH TECHNOLOGY ASSESSMENTS: SYNTHESIS OF GUIDANCE DOCUMENTS AND THE LITERATURE
International Journal of Technology Assessment in Health Care, 2012, 28, 36-43
0.125Citations (PDF)
154Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program
Journal of Clinical Epidemiology, 2011, 64, 1187-1197
0.7575Citations (PDF)
155Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program
Journal of Clinical Epidemiology, 2011, 64, 1198-1207
0.764Citations (PDF)
156Nutzen-Schaden Abwägung von bevölkerungsbezogenen Interventionen am Beispiel von Krebs-Screening
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2011, 105, 176-182
0.21Citations (PDF)
157Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder
Annals of Internal Medicine, 2011, 155, 772
2.1324Citations (PDF)
158Österreichische Patienteninformationsmaterialien zu PSA-Screening entsprechen nicht internationalen evidenzbasierten Standards
Wiener Medizinische Wochenschrift, 2011, 161, 89-98
0.28Citations (PDF)
159Clinical outcome after microfracture of the knee: a meta-analysis of before/after-data of controlled studies
International Orthopaedics, 2011, 36, 43-50
0.548Citations (PDF)
160Semi‐automating the manual literature search for systematic reviews increases efficiency
Health Information and Libraries Journal, 2010, 27, 22-27
0.575Citations (PDF)
161Differences in Efficacy and Safety of Pharmaceutical Treatments between Men and Women: An Umbrella Review
PLoS ONE, 2010, 5, e11895
0.420Citations (PDF)
162The effect of study sponsorship on a systematically evaluated body of evidence of head-to-head trials was modest: secondary analysis of a systematic review
Journal of Clinical Epidemiology, 2010, 63, 117-125
0.721Citations (PDF)
163Pharmaceutical company–sponsored drug trials: the system is broken
Journal of Clinical Epidemiology, 2010, 63, 128-129
0.77Citations (PDF)
164Comparative effectiveness reviews and the impact of funding bias
Journal of Clinical Epidemiology, 2010, 63, 589-590
0.75Citations (PDF)
165Inadequate reporting of trials compromises the applicability of systematic reviews
International Journal of Technology Assessment in Health Care, 2009, 25, 323-330
0.19Citations (PDF)
166Are all antidepressants equal?
Evidence-Based Mental Health, 2009, 12, 98-100
5.24Citations (PDF)
167Are some antidepressants better than others?
Nature Reviews Neurology, 2009, 5, 239-240
4.74Citations (PDF)
168Bach Flower Remedies for psychological problems and pain: a systematic review
BMC Complementary and Alternative Medicine, 2009, 9,
3.737Citations (PDF)
169Diagnostische Studien
Wiener Medizinische Wochenschrift, 2009, 159, 359-366
0.25Citations (PDF)
170Low-Density-Lipoprotein-Apherese bei familiärer Hypercholesterinämie
Medizinische Klinik, 2009, 104, 1-9
0.23Citations (PDF)
171Ranking antidepressants
Lancet, The, 2009, 373, 1761
2.811Citations (PDF)
172Systematische Übersichtsarbeiten und Meta-Analysen
Wiener Medizinische Wochenschrift, 2008, 158, 127-133
0.27Citations (PDF)
173Kohortenstudien
Wiener Medizinische Wochenschrift, 2008, 158, 174-179
0.21Citations (PDF)
174Randomisiert kontrollierte Studien
Wiener Medizinische Wochenschrift, 2008, 158, 234-239
0.212Citations (PDF)
175Health Technology Assessment – evaluating health care interventions
Wiener Medizinische Wochenschrift, 2008, 158, 522-529
0.21Citations (PDF)
176Strategies in assessing the need for updating evidence-based guidelines for six clinical topics: an exploration of two search methodologies
Health Information and Libraries Journal, 2008, 25, 198-207
0.53Citations (PDF)
177Treating the Physical Symptoms of Depression With Second-Generation Antidepressants: A Systematic Review and Metaanalysis
Psychosomatics, 2008, 49, 191-198
2.529Citations (PDF)
178Assessment of adverse effects and applicability – two areas not (yet) covered adequately in Cochrane reports
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen, 2008, 102, 497-502
0.218Citations (PDF)
179Direct versus indirect comparisons: A summary of the evidence
International Journal of Technology Assessment in Health Care, 2008, 24, 170-177
0.160Citations (PDF)
180Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
Annals of Internal Medicine, 2008, 148, 124
2.1254Citations (PDF)
181Meta-analysis of Major Depressive Disorder Relapse and Recurrence With Second-Generation Antidepressants
Psychiatric Services, 2008, 59, 1121-1130
0.573Citations (PDF)
182Authors' reply to comment on: a simple and valid tool distinguished efficacy from effectiveness studies
Journal of Clinical Epidemiology, 2007, 60, 755
0.72Citations (PDF)
183Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events
Clinical Gastroenterology and Hepatology, 2007, 5, 729-735.e1
1.7101Citations (PDF)
184Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
Clinical Rheumatology, 2007, 27, 67-76
0.470Citations (PDF)
185A simple and valid tool distinguished efficacy from effectiveness studies
Journal of Clinical Epidemiology, 2006, 59, 1040-1048
0.7190Citations (PDF)
186Cesarean Delivery on Maternal Request
Obstetrics and Gynecology, 2006, 108, 1517-1529
0.3127Citations (PDF)
187Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes
Annals of Family Medicine, 2006, 4, 253-262
0.4119Citations (PDF)
188Perinatal Depression
Obstetrics and Gynecology, 2005, 106, 1071-1083
0.32,918Citations (PDF)
189Efficacy and Safety of Second-Generation Antidepressants in the Treatment of Major Depressive Disorder
Annals of Internal Medicine, 2005, 143, 415
2.1229Citations (PDF)
190Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis
International Clinical Psychopharmacology, 2005, 20, 59-69
0.654Citations (PDF)
191Outcomes of Routine Episiotomy
JAMA - Journal of the American Medical Association, 2005, 293, 2141
1.6368Citations (PDF)
192Assessing the need to update prevention guidelines: a comparison of two methods
International Journal for Quality in Health Care, 2004, 16, 399-406
0.235Citations (PDF)
193Evidence-based medicine breaking the borders – A working model for the European Union to facilitate evidence-based health care
Wiener Medizinische Wochenschrift, 2004, 154, 127-132
0.26Citations (PDF)
194Second-generation antidepressants for seasonal affective disorder
The Cochrane Library, 0, ,
0.530Citations (PDF)
195Antidepressants for the treatment of abdominal pain-related functional gastrointestinal disorders in children and adolescents
The Cochrane Library, 0, ,
0.537Citations (PDF)
196Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
The Cochrane Library, 0, ,
0.550Citations (PDF)
197Second-generation antidepressants for preventing seasonal affective disorder in adults
The Cochrane Library, 0, ,
0.519Citations (PDF)
198Psychological therapies for preventing seasonal affective disorder
The Cochrane Library, 0, ,
0.516Citations (PDF)
199Melatonin and agomelatine for preventing seasonal affective disorder
The Cochrane Library, 0, ,
0.518Citations (PDF)
200Light therapy for preventing seasonal affective disorder
The Cochrane Library, 0, ,
0.556Citations (PDF)
201Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
BMJ, The, 0, , h6019
0.2149Citations (PDF)
202Ezetimibe-Statin Combination Therapy: Efficacy and Safety as Compared With Statin Monotherapy
Deutsches A&amp;#x0308;rzteblatt International, 0, ,
0.122Citations (PDF)
203Taxation of the fat content of foods for reducing their consumption and preventing obesity or other adverse health outcomes
The Cochrane Library, 0, ,
0.59Citations (PDF)
204Taxation of unprocessed sugar or sugar-added foods for reducing their consumption and preventing obesity or other adverse health outcomes
The Cochrane Library, 0, ,
0.514Citations (PDF)
205Taxation of sugar-sweetened beverages for reducing their consumption and preventing obesity or other adverse health outcomes
The Cochrane Library, 0, ,
0.528Citations (PDF)
206Household interventions for preventing domestic lead exposure in children
The Cochrane Library, 0, ,
0.536Citations (PDF)
207Nivolumab for adult individuals with Hodgkin lymphoma (an exemplar rapid review using RobotReviewer)
The Cochrane Library, 0, ,
0.53Citations (PDF)
208Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review
The Cochrane Library, 0, ,
0.51Citations (PDF)
209Psychological therapies for preventing seasonal affective disorder
The Cochrane Library, 0, ,
0.57Citations (PDF)
210Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review
The Cochrane Library, 0, ,
0.5598Citations (PDF)
211In Reply
Deutsches A&amp;#x0308;rzteblatt International, 0, ,
0.10Citations (PDF)
212Surgical and Non-Surgical Interventions in Complete Rotator Cuff Tears
Deutsches A&amp;#x0308;rzteblatt International, 0, ,
0.17Citations (PDF)